281 related articles for article (PubMed ID: 28376789)
1. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
[TBL] [Abstract][Full Text] [Related]
2. Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India.
Shewade HD; Nair D; Klinton JS; Parmar M; Lavanya J; Murali L; Gupta V; Tripathy JP; Swaminathan S; Kumar AMV
J Epidemiol Glob Health; 2017 Dec; 7(4):227-233. PubMed ID: 29110862
[TBL] [Abstract][Full Text] [Related]
3. Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors.
Xu C; Li R; Shewade HD; Jeyashree K; Ruan Y; Zhang C; Wang L; Zhang H
PLoS One; 2019; 14(4):e0214943. PubMed ID: 30958841
[TBL] [Abstract][Full Text] [Related]
4. Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.
Shewade HD; Kokane AM; Singh AR; Parmar M; Verma M; Desikan P; Khan SN; Kumar AMV
PLoS One; 2018; 13(4):e0196162. PubMed ID: 29677210
[TBL] [Abstract][Full Text] [Related]
5. Delay before drug susceptibility testing among patients with presumptive multidrug-resistant tuberculosis in Gujarat, India.
Shewade HD; Shringarpure KS; Parmar M; Patel N; Kuriya S; Shihora S; Ninama N; Gosai N; Khokhariya R; Popat C; Thanki H; Modi B; Dave P; Baxi RK; Kumar AMV
Trans R Soc Trop Med Hyg; 2018 Nov; 112(11):500-508. PubMed ID: 30137546
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
[TBL] [Abstract][Full Text] [Related]
8. The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh.
Hossain ST; Isaakidis P; Sagili KD; Islam S; Islam MA; Shewade HD; Kamal SM; Husain A
PLoS One; 2015; 10(6):e0129155. PubMed ID: 26110273
[TBL] [Abstract][Full Text] [Related]
9. Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain
Timire C; Sandy C; Kumar AMV; Ngwenya M; Murwira B; Takarinda KC; Harries AD
Int J Infect Dis; 2019 Apr; 81():236-243. PubMed ID: 30776546
[TBL] [Abstract][Full Text] [Related]
10. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.
Isaakidis P; Das M; Kumar AM; Peskett C; Khetarpal M; Bamne A; Adsul B; Manglani M; Sachdeva KS; Parmar M; Kanchar A; Rewari BB; Deshpande A; Rodrigues C; Shetty A; Rebello L; Saranchuk P
PLoS One; 2014; 9(10):e110461. PubMed ID: 25333696
[TBL] [Abstract][Full Text] [Related]
11. A study on procedural delay in diagnosis and start of treatment in drug resistant tuberculosis under RNTCP.
Sharma AK; Gupta N; Verma S; Chandran A; Dixit R
Indian J Tuberc; 2019 Jul; 66(3):394-401. PubMed ID: 31439186
[TBL] [Abstract][Full Text] [Related]
12. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
[TBL] [Abstract][Full Text] [Related]
13. Uptake of universal drug susceptibility testing among people with TB in a south Indian district: How are we faring?
Ranganath R; Shewade HD; Bahadur AK; Naik V; Nagaraja SB; Kumar AMV; Peerapur BV; Babu S; Somshekhar N; Singarajipur A
Trans R Soc Trop Med Hyg; 2022 Jan; 116(1):43-49. PubMed ID: 33823556
[TBL] [Abstract][Full Text] [Related]
14. MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway.
Shewade HD; Govindarajan S; Thekkur P; Palanivel C; Muthaiah M; Kumar AM; Gupta V; Sharath BN; Tripathy JP; Vivekananda K; Roy G
Public Health Action; 2016 Dec; 6(4):242-246. PubMed ID: 28123961
[No Abstract] [Full Text] [Related]
15. Has universal screening with Xpert® MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?
Naidoo P; Dunbar R; Caldwell J; Lombard C; Beyers N
PLoS One; 2017; 12(2):e0172143. PubMed ID: 28199375
[TBL] [Abstract][Full Text] [Related]
16. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.
Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
Int J Infect Dis; 2020 Jul; 96():390-397. PubMed ID: 32353546
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the health system barriers to early diagnosis and management of multidrug-resistant tuberculosis in a rural setting in North India.
Bashar MA; Aggarwal A; Bhattacharya S
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31969399
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of rifampin-resistant tuberculosis in mountainous districts of India.
Dorjee K; Sadutshang TD; Rana RS; Topgyal S; Phunkyi D; Choetso T; Chodon T; Parmar M; Singla R; Paster Z; Chaisson RE; Kaushal KC
Indian J Tuberc; 2020 Jan; 67(1):59-64. PubMed ID: 32192619
[TBL] [Abstract][Full Text] [Related]
20. Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India.
Chadha SS; Sharath BN; Reddy K; Jaju J; Vishnu PH; Rao S; Parmar M; Satyanarayana S; Sachdeva KS; Wilson N; Harries AD
PLoS One; 2011; 6(11):e26659. PubMed ID: 22073182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
